Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
DTS INC DTSI
6.89%
ANIKA THERAP ANIK
6.04%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%

Schwab Expects Costs to Rise

by Zacks Equity Research

May 09, 2011 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Last week, Charles Schwab Corp. (SCHW - Analyst Report) announced its expectation for capital spending on client-related initiatives to increase approximately 40% in 2011 over 2010.

The company increased its earlier projection of 35% increment mentioned in 2010 annual report filed at the end of February 2011 to 40%, driven by anticipated increase in spending on software, equipment related to computer systems and leasehold improvements.

Specifically, Schwab’s spending plan includes significant improvement in service areas like fixed-income, global investing, mobile and tablet solutions, and advisor-focused technology, coupled with advancement of index-and-ETF-based 401(k) and Independent Branch Services initiatives.

In 2010, Schwab's capital expenditures were $127 million, or 3% of net revenue. Based on current assumptions, spending is expected to climb by more than $50 million to $178 million in 2011.

According to Schwab, if low-interest rate environment persists, constrained growth in net interest revenue with the erosion of asset management fees will be recorded in the forthcoming quarters.

The company’s initiatives to enhance growth through investments in the coming years will help it sustaining the better revenue over the long term with a strong client network.

As a part of growth initiative, in March 2011, Schwab had announced an all-stock deal to acquire optionsXpress Holdings Inc. (OXPS) for $1.0 billion. Under the agreement, the company will offer 1.02 shares for each share of optionsXpress.

The deal is valued at $17.91 per share or 17% premium to the closing price of optionsXpress’ stock as of March 18. The company anticipates the deal to be modestly accretive and expect synergies worth $80 million in the first full year of combined operations.

Earnings Recap

Schwab’s first-quarter 2011 earnings came in at 20 cents per share, a penny ahead of the Zacks Consensus Estimate of 19 cents. This also compares favorably with the year-ago quarter’s earnings of 11 cents. The results benefited from improved revenue and increase in interest-earning assets. Additionally, fall in non-interest expenses was also a positive for the company.

Our Take

While focus on lower-cost capital structure will sustain better results in the upcoming quarters, Schwab’s financials will continue to be impacted by lower trading activity and volatile interest rates. However, after the completion of the optionsXpress, the company’s top line will benefit from increased trading in derivatives and capital spending initiatives will augment further revenue growth.

CharlesSchwab currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Moreover, considering the fundamentals, we maintain our long-term Neutral recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.